West Pharmaceutical Services, Inc. (WST) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $371.09 --0%
EPS Growth %: +11.7%
Financial Fact:
Operating profit: 51.3M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +11.7%
Financial Fact:
Operating profit: 51.3M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q2 EPS of $0.79, $0.10 better than the analyst estimate of $0.69. Revenue for the quarter came in at $324.8 million versus the consensus estimate of $321.5 million.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Activist Jana Partners calls for Six Flags sale - WSJ
- AppLovin drops 3% as Edgewater analyst warns of stalled market share growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
